Detalhe da pesquisa
1.
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.
Mol Cell
; 77(3): 633-644.e5, 2020 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31836388
2.
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.
Mol Cell
; 77(3): 681, 2020 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32032511
3.
Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity.
Cell Rep
; 42(10): 113224, 2023 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37805922
4.
ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression.
Dev Cell
; 57(3): 329-343.e7, 2022 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085484
5.
Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapy.
Cancer Cell
; 40(10): 1173-1189.e6, 2022 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36220073
6.
Dichotomous and stable gamma delta T-cell number and function in healthy individuals.
J Immunother Cancer
; 9(5)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011536
7.
Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving Immunotherapy.
J Natl Cancer Inst
; 113(2): 162-170, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294209
8.
SARS-CoV-2 seropositivity and seroconversion in patients undergoing active cancer-directed therapy.
medRxiv
; 2021 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33469597
9.
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer.
Nat Med
; 27(7): 1280-1289, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34017137
10.
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer.
Res Sq
; 2021 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33564756
11.
SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy.
JCO Oncol Pract
; 17(12): e1879-e1886, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34133219
12.
Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer.
Cell Rep
; 33(13): 108571, 2020 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33378668
13.
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control.
Cancer Immunol Res
; 7(8): 1371-1380, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31239316